IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q1 2024 Holdings

Filed 2024-05-13 | 3 holdings | $206.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$152.5M19,201,47573.9%
Pliant Therapeutics, Inc.(PLRX)COM729139105$31.8M2,132,86715.4%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$22.1M2,343,15410.7%